AMARIN CORP PLC -ADR (AMRN)
US0231112063 - ADR
AMARIN CORP PLC -ADR
NASDAQ:AMRN (4/25/2024, 7:00:00 PM)
After market: 0.8729 +0.01 (+1.49%)0.8601
-0.02 (-2.11%)
Company Profile
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The firm operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Company Info
AMARIN CORP PLC -ADR
First Floor, Block 3, The Oval,, Shelbourne Road, Ballsbridge
DUBLIN Dublin 2
P: 35316699020
CEO: John F. Thero
Employees: 365
Website: https://amarincorp.com/
AMRN News
a day ago - Amarin Corporation plcAmarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular EventCitizen Petition Spotlights Risks for Patients on Drug Proven to Have No Benefit in Improving Cardiovascular Outcomes and Need for Urgent Regulatory Action to Protect Patients
Citizen Petition Spotlights Risks for Patients on Drug Proven to Have No Benefit in Improving Cardiovascular Outcomes and Need for Urgent Regulatory Action...
4 days ago - Amarin Corporation plcAmarin Announces Results of Annual General Meeting of Shareholders- Shareholders Approve Share Repurchase Program of up to $50 Million -
- Shareholders Approve Share Repurchase Program of up to $50 Million -...
11 days ago - Amarin Corporation plcAmarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 202418 days ago - Amarin Corporation plcAmarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanism of Action
AMRN Twits
Here you can normally see the latest stock twits on AMRN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
